Enveric Biosciences Deepens Its Mental Health-Focused Pipeline With Library of Preclinical Compounds [Benzinga]
Wednesday, February 21, 2024 1 min read
Key Takeaway: Enveric Biosciences has announced the discovery of several new compounds through its Psybrary platform, utilizing advanced computational chemistry and AI. These compounds represent seven distinct molecule classes, providing at least 57 unique product opportunities. The innovations are safeguarded by Enveric's extensive intellectual property portfolio.
Price reaction · baseline $155.862 (2024-02-20 close) · hit pre-market · 3 other ENVB headline(s) in the window, move may be shared
day 0 close
-1%
Market Sentiment Analysis
POSITIVE FACTORS
Discovery of multiple compounds enhances the pipeline.
Use of AI in drug discovery indicates innovation.
Expansive intellectual property portfolio protects new products.
Full Press Release Details
Enveric Biosciences announced the discovery of multiple compounds sourced using its Psybrary platform and proprietary computational chemistry and artificial intelligence (AI) drug-discovery system (PsyAI). The compounds span seven distinct molecule classes totaling at least 57 unique product opportunities, all protected by Enveric’s expansive intellectual property portfolio.
Full Article >>
Frequently Asked Questions
What platform did Enveric use for compound discovery?
Enveric used its Psybrary platform for discovering new compounds.
How many unique product opportunities were identified?
At least 57 unique product opportunities were identified.
What technology aids Enveric's drug discovery?
Enveric employs AI and computational chemistry in its drug discovery process.
How many molecule classes do the new compounds span?
The new compounds span seven distinct molecule classes.